Categorie -wet- en regelgeving

bv CGR, GDPR

wet- en regelgeving

ViiV’s two-drug regimen gets EU approval for HIV-1

30 mei 2018

Pharmafile

wet- en regelgeving

EMA review confirms risks of Abbvie and Biogen’s Zinbryta outweigh benefits

30 mei 2018

Pharmafile

wet- en regelgeving

Amgen/Novartis potential blockbuster migraine gets FDA nod

30 mei 2018

Pharmafile

wet- en regelgeving

BioMarin receives FDA nod for its would-be blockbuster

28 mei 2018

Pharmafile

wet- en regelgeving

Novartis’ Sandoz scores EU approval for Remicade biosimilar

28 mei 2018

Pharmafile

wet- en regelgeving

FDA approves AZ’s Lokelma for hyperkalaemia

22 mei 2018

Pharmafile

Medhc-fases-banner

Advertentie(s)

Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer